PCRX icon

Pacira BioSciences
PCRX

Overview Fund Activity

183 hedge funds and large institutions have $1.38B invested in Pacira BioSciences in 2016 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 77 increasing their positions, 40 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
183
Holders Change
+3
Holders Change %
+1.67%
% of All Funds
4.89%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.08%
New
45
Increased
77
Reduced
40
Closed
41
Calls
$5.63M
Puts
$13.7M
Net Calls
-$8.06M
Net Calls Change
-$3.64M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$188M
2
Westfield Capital Management
2
Westfield Capital Management
Massachusetts
$45M
3
Citadel Advisors
3
Citadel Advisors
Florida
$18.1M
4
Schroder Investment Management Group
4
Schroder Investment Management Group
United Kingdom
$16.2M
5
Millennium Management
5
Millennium Management
New York
$26.4M

Top Sellers

1
VAM
1
Visium Asset Management
New York
$0
2
MC
2
Maverick Capital
Texas
$0
3
FAM
3
Fred Alger Management
New York
$6.71M
4
Jennison Associates
4
Jennison Associates
New York
$0
5
CCI
5
Columbus Circle Investors
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
ECP
26
Elk Creek Partners
Colorado
$14.7M +$1.52M +45,141 +12%
VOYA Investment Management
27
VOYA Investment Management
Georgia
$12.3M +$3.16M +93,563 +34%
Morgan Stanley
28
Morgan Stanley
New York
$12M +$9.99M +296,240 +494%
Wells Fargo
29
Wells Fargo
California
$12M -$7.18M -212,881 -37%
Norges Bank
30
Norges Bank
Norway
$10.6M +$3.52M +104,298 +50%
FHAM
31
Folger Hill Asset Management
New York
$10.4M +$3.98M +118,010 +62%
Deutsche Bank
32
Deutsche Bank
Germany
$10.2M +$433K +12,832 +4%
Geode Capital Management
33
Geode Capital Management
Massachusetts
$9.91M +$1.06M +31,329 +12%
Point72 Asset Management
34
Point72 Asset Management
Connecticut
$9.49M +$9.49M +281,236 New
EAM
35
EverPoint Asset Management
Connecticut
$8.94M +$8.94M +265,000 New
HM
36
HealthCor Management
New York
$8.43M +$8.43M +250,000 New
Ameriprise
37
Ameriprise
Minnesota
$8.05M +$1.36M +40,183 +20%
KCM
38
Key Colony Management
Arkansas
$7.45M -$2.7M -79,975 -27%
Baillie Gifford & Co
39
Baillie Gifford & Co
United Kingdom
$7.21M +$6.28M +186,100 +677%
KCM
40
Kingdon Capital Management
New York
$7.13M +$7.13M +211,500 New
Two Sigma Investments
41
Two Sigma Investments
New York
$7.08M +$4.92M +145,780 +228%
GIM
42
Granahan Investment Management
Massachusetts
$7.03M +$1.67M +49,500 +31%
FAM
43
Fred Alger Management
New York
$6.71M -$55.9M -1,658,544 -89%
UBS AM
44
UBS AM
Illinois
$6.67M +$2.17M +64,284 +48%
Bank of Montreal
45
Bank of Montreal
Ontario, Canada
$6.47M -$1.15M -34,115 -15%
TA
46
Tamarack Advisers
California
$6.41M +$6.41M +190,000 New
Bank of New York Mellon
47
Bank of New York Mellon
New York
$6.17M -$615K -18,234 -9%
BIA
48
Biondo Investment Advisors
Pennsylvania
$5.56M -$527K -15,632 -9%
SO
49
STRS Ohio
Ohio
$5.4M -$1.39M -41,300 -21%
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$5.1M +$3.48M +103,178 +215%
1
2
3 4 5